R1 RCM Inc. (RCM)
NASDAQ: RCM · IEX Real-Time Price · USD
12.86
-0.13 (-1.00%)
May 31, 2024, 4:00 PM EDT - Market closed
R1 RCM Revenue
R1 RCM had revenue of $2.31B in the twelve months ending March 31, 2024, with 17.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $603.90M with 10.69% year-over-year growth. In the year 2023, R1 RCM had annual revenue of $2.25B with 24.79% growth.
Revenue (ttm)
$2.31B
Revenue Growth
+17.61%
P/S Ratio
2.34
Revenue / Employee
$77,083
Employees
30,000
Market Cap
5.42B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.25B | 447.80M | 24.79% |
| Dec 31, 2022 | 1.81B | 331.80M | 22.50% |
| Dec 31, 2021 | 1.47B | 204.50M | 16.10% |
| Dec 31, 2020 | 1.27B | 84.00M | 7.08% |
| Dec 31, 2019 | 1.19B | 317.60M | 36.57% |
| Dec 31, 2018 | 868.50M | 418.70M | 93.09% |
| Dec 31, 2017 | 449.80M | -142.80M | -24.10% |
| Dec 31, 2016 | 592.60M | 475.40M | 405.63% |
| Dec 31, 2015 | 117.20M | -92.94M | -44.23% |
| Dec 31, 2014 | 210.14M | -294.63M | -58.37% |
| Dec 31, 2013 | 504.77M | 432.51M | 598.60% |
| Dec 31, 2012 | 72.25M | -29.71M | -29.14% |
| Dec 31, 2011 | 101.97M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Organon & Co. | 6.35B |
| Option Care Health | 4.43B |
| Bausch + Lomb | 4.31B |
| Stevanato Group | 1.18B |
| Halozyme Therapeutics | 862.99M |
| Ionis Pharmaceuticals | 776.62M |
| Doximity | 475.42M |
| BridgeBio Pharma | 218.60M |
RCM News
- 9 days ago - R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference - GlobeNewsWire
- 25 days ago - R1 RCM Reports First Quarter 2024 Results - GlobeNewsWire
- 4 weeks ago - R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference - GlobeNewsWire
- 2 months ago - R1 RCM to Release First Quarter 2024 Results on May 8, 2024 - GlobeNewsWire
- 2 months ago - R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report - GlobeNewsWire
- 3 months ago - R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Business Wire
- 3 months ago - R1 RCM Reports Fourth Quarter and Full Year 2023 Results - GlobeNewsWire
- 3 months ago - Coliseum Capital Issues Open Letter to Board of R1 RCM on Offer by New Mountain to Acquire the Company for $13.75 Per Share - Business Wire